28 research outputs found
A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
This study was designed to evaluate the activity, safety and tolerance of docetaxel (D) in a selected population with metastatic squamous cell carcinoma of the head and neck (SCCHN). Twenty-four patients with no prior palliative therapy were enrolled and received D 100 mg mâ2 by 1 h of infusion, every 3 weeks. All but two patients had been evaluated for efficacy on lung metastatic sites. No prophylactic administration of anti-emetics or growth factors was given. A pharmacokinetic study was performed in 22 patients. Twenty-one patients were assessable for response and 24 for toxicity. One hundred and four cycles were administered with a median of 4.5 (range 1â9) per patient. The median cumulative dose was 449 mg mâ2. Partial responses were achieved in five patients with a median duration of 18.7 weeks (range 13.1â50.3). The overall response rate was 20.8% with a median duration of 11.0 weeks (range 2.4â52.6). The most frequent side-effect was neutropenia (79.2% grade IV) but with a short duration (median 4 days) and no febrile neutropenia. The incidence of moderate/severe fluid retention was 29.2% with one treatment discontinuation. Other toxicities (all grades) were common (skin 75%, asthenia 50%, infection 29.2%, nausea 16.7%, diarrhoea 12.5%, stomatitis 16.7%, vomiting 8.3% and HSR 8.3%). A mean clearance of 19.6 l hâ1 mâ2 and an area under the curve of 6.00 ÎŒg mlâ1 hâ1 was found in the pharmacokinetic analysis. Docetaxel is active in this selected population with metastatic SCCHN, with a good tolerance. © 1999 Cancer Research Campaig
âTo the land or to the sea' : diet and mobility in early medieval Frisia
This study investigated palaeodiet and population mobility in early medieval Frisia through the stable isotope analysis of individuals buried in the fifthâeighth century AD cemetery of Oosterbeintum, a terp site on the northern coast of the Netherlands. The results cast new light on the role of the northern Netherlands in trade and migration in the early medieval period, and have significance for the study of interaction and movement throughout the wider North Sea region. Bone collagen and tooth enamel from humans and animals were analyzed using carbon, nitrogen, oxygen, and strontium isotopes. ÎŽ13C and ÎŽ15N results indicated that the population had a terrestrial, C3-based diet. High ÎŽ15N values were observed in humans and fauna, which are probably related to the terp's salt-marsh location. The ÎŽ18O and 87Sr/86Sr data revealed a high proportion of non-locals buried at Oosterbeintum, some of whom had probably migrated from regions as distant and varied as Scandinavia and southern England. It is suggested that this immigration may be associated with Frisian maritime trading activities. New data are also presented from a small number of contemporaneous European sites
Comprehensive in vitro and in vivo studies of novel melt-derived Nb-substituted 45S5 bioglass reveal its enhanced bioactive properties for bone healing
The present work presents and discusses the results of a comprehensive study on the bioactive properties of Nb-substituted silicate glass derived from 45S5 bioglass. In vitro and in vivo experiments were performed. We undertook three different types of in vitro analyses: (i) investigation of the kinetics of chemical reactivity and the bioactivity of Nb-substituted glass in simulated body fluid (SBF) by 31P MASNMR spectroscopy, (ii) determination of ionic leaching profiles in buffered solution by inductively coupled plasma optical emission spectrometry (ICP-OES), and (iii) assessment of the compatibility and osteogenic differentiation of human embryonic stem cells (hESCs) treated with dissolution products of different compositions of Nb-substituted glass. The results revealed that Nb-substituted glass is not toxic to hESCs. Moreover, adding up to 1.3âmol% of Nb2O5 to 45S5 bioglass significantly enhanced its osteogenic capacity. For the in vivo experiments, trial glass rods were implanted into circular defects in rat tibia in order to evaluate their biocompatibility and bioactivity. Results showed all Nb-containing glass was biocompatible and that the addition of 1.3âmol% of Nb2O5, replacing phosphorous, increases the osteostimulation of bioglass. Therefore, these results support the assertion that Nb-substituted glass is suitable for biomedical applications
Trade and Exchange in Anglo-Saxon Wessex, AD 600-780
This paper assesses the provenance and general distribution of coins of the period c 600âc 780 found in the west of AngloâSaxon Wessex. It shows that the distribution of coin finds is not a function of the habits of metal detectorists, but a reflection of the real pattern of losses. In the second part of the paper, an analysis of the observed distributions is presented which reveals that the bulk of trade, of which the coins are a sign, was carried on through local ports and that foreign trade was not mediated through Hamwic, but came directly from the continent. The distribution of coin finds also suggests an important export trade, probably in wool and woollen goods, controlled from major local centres. There are also hints of a potentially older trade system in which hillforts and other open sites were important
Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors
Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors.
Purpose: To define the maximum tolerated dose (MTD), the recommended phase II dose, the optimal infusion duration and pharmacokinetics of the semisynthetic taxoid derivative RPR 109881 A, given as a 1-h or 3-h infusion every 3 weeks.
Patients and methods: RPR109881A was administered as a 1-h i.v. infusion to 34 patients (study 1) with oral steroids as pre-medication. In a subsequent study, 29 patients were treated at the recommended dose or at the dose immediately below (study 2); the first 14 patients received RPR109881A as a 3-h infusion, while the subsequent 15 were randomized to receive the drug as a 1-h or 3-h infusion. The pharmacokinetics of RPR109881A was studied in plasma and urine and for selected patients in some biological fluids (cerebrospinal fluid, pleural effusion, ascitis).
Results: In study 1, the dose was escalated from 15 to 105 mg/m(2), at which dose two of five patients presented dose-limiting toxicities with febrile neutropenia (FN) after the first cycle, thus defining the MTD. The dose of 90 mg/m(2), at which grade 3/4 neutropenia was almost universal with FN in 18%, was recommended for phase II. At 90 mg/m(2) the incidence of diarrhea, fatigue and alopecia were 59, 29 and 70%, respectively. The results of study 2 were comparable to those of study 1, thus recommending the 1-h infusion duration for phase 11 evaluation. RPR 109881 A exhibited a high total body clearance, a large distribution volume and long terminal half-life of 20 It. RPR 10988 1 A was detected in cerebrospinal fluid shortly after the end of 1-h infusion. Three objective responses were observed in non-small-cell lung cancer (NSCLC) patients, including a patient with brain metastases.
Conclusions: The antitumor activity in NSCLC, the reproducible profile of toxicity and above all the ability to cross the blood-brain barrier make RPR 10988 1 A worthy of further disease-oriented clinical development
Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors
Purpose: To define the maximum tolerated dose (MTD), the recommended phase II dose, the optimal infusion duration and pharmacokinetics of the semisynthetic taxoid derivative RPR 109881A, given as a 1-h or 3-h infusion every 3 weeks. Patients and methods: RPR109881A was administered as a 1-h i.v. infusion to 34 patients (study 1) with oral steroids as pre-medication. In a subsequent study, 29 patients were treated at the recommended dose or at the dose immediately below (study 2); the first 14 patients received RPR 109881A as a 3-h infusion, while the subsequent 15 were randomized to receive the drug as a 1-h or 3-h infusion. The pharmacokinetics of RPR109881A was studied in plasma and urine and for selected patients in some biological fluids (cerebrospinal fluid, pleural effusion, ascitis). Results: In study 1, the dose was escalated from 15 to 105 mg/m2, at which dose two of five patients presented dose-limiting toxicities with febrile neutropenia (FN) after the first cycle, thus defining the MTD. The dose of 90 mg/m2, at which grade 3/4 neutropenia was almost universal with FN in 18%, was recommended for phase II. At 90 mg/m2 the incidence of diarrhea, fatigue and alopecia were 59, 29 and 70%, respectively. The results of study 2 were comparable to those of study 1, thus recommending the 1-h infusion duration for phase II evaluation. RPR 109881A exhibited a high total body clearance, a large distribution volume and long terminal half-life of 20 h. RPR 109881A was detected in cerebrospinal fluid shortly after the end of 1-h infusion. Three objective responses were observed in non-small-cell lung cancer (NSCLC) patients, including a patient with brain metastases. Conclusions: The antitumor activity in NSCLC, the reproducible profile of toxicity and above all the ability to cross the blood-brain barrier make RPR 109881A worthy of further disease-oriented clinical developmen
Horizons marins, itinéraires spirituels (Ve-XVIIIe siÚcles). Volume II.
Les 26 contributions rĂ©unies dans ce volume renouvellent quelques-uns des secteurs de l'histoire maritime, en attirant l'attention sur la mĂ©thodologie, les recherches rĂ©centes, les problĂ©matiques nouvelles, la recherche interdisciplinaire, l'archĂ©ologie, l'iconographie et le roman. On suit pendant deux millĂ©naires quelques-uns des nombreux changements qui ont affectĂ© les façades ocĂ©aniques des cinq continents, en AmĂ©rique latine comme Ă Madagascar et dans l'OcĂ©an Indien, sur les rivages de la MĂ©diterranĂ©e comme dans le commerce eurasien. Quelques thĂšmes demeurent privilĂ©giĂ©s, les navires et la navigation, les marines de guerre et les politiques navales des Ătats, l'exploitation des littoraux et les installations portuaires, les marchandises et les frets, les tonnages et les mesures, les assurances maritimes. Les marins, voyageurs, pĂšlerins, missionnaires, marchands, tous ces gens de mer occupent une grande place dans cet ouvrage, qui traite de la famille, de la formation et des apprentissages, de la santĂ© et des maladies professionnelles, des croyances et des genres de vie. Ce volume qui fait toute sa place Ă l'histoire des mentalitĂ©s s'honore de multiples contributions internationales et de la collaboration de quelques spĂ©cialistes, mĂ©decin, architecte naval..., issus des gens de mer